dactinomycin has been researched along with etidronate in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hsu, TH | 1 |
Ryan, WG | 1 |
Ryan, WG; Schwartz, TB | 1 |
1 review(s) available for dactinomycin and etidronate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for dactinomycin and etidronate
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Current diagnosis and management of Paget's disease of bone.
Topics: Calcitonin; Dactinomycin; Etidronic Acid; Glucagon; Humans; Osteitis Deformans; Plicamycin | 1977 |
Paget's disease of bone.
Topics: Adult; Bone and Bones; Calcitonin; Calcium; Collagen; Dactinomycin; Etidronic Acid; Fluorides; Glucagon; Humans; Hydroxyproline; Osteitis Deformans; Parathyroid Hormone; Phosphates; Plicamycin; Regional Blood Flow | 1977 |
Treatment of Paget's disease of bone.
Topics: Animals; Bone Resorption; Calcitonin; Dactinomycin; Etidronic Acid; Glucagon; Humans; Osteitis Deformans; Osteoporosis; Plicamycin; Rats | 1973 |
Mithramycin treatment of Paget's disease of bone. Exploration of combined mithramycin-EHDP therapy.
Topics: Aged; Alkaline Phosphatase; Antibiotics, Antineoplastic; Binding, Competitive; Dactinomycin; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Kidney; Liver; Male; Middle Aged; Osteitis Deformans; Platelet Count; Plicamycin; RNA | 1980 |